SCHEMBL6137977

SCHEMBL6137977

N=C(N)N(Cc1ccccc1)C(=O)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.47
MAPT P10636 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TAS2R14 Q9NYV8 2/20 0.46
CXCR3 P49682 1/20 0.46
GRIN2B Q13224 2/20 0.45
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
TMEM97 Q5BJF2 3/20 0.45
SIGMAR1 Q99720 3/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
HTT P42858 1/20 0.43
CES2 O00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137702 0.85 MEN1 (0.47) L3MBTL1MAPTMEN1KMT2ATAS2R14
SCHEMBL6137934 0.82 SCN5A (0.49) AGERL3MBTL1MAPTMEN1KMT2A
SCHEMBL6137828 0.82 ACHE (0.56) L3MBTL1MEN1KMT2ATAS2R14CXCR3
SCHEMBL6137987 0.81 L3MBTL1 (0.48) AGERL3MBTL1MAPTMEN1KMT2A
SCHEMBL6137989 0.80 AGER (0.42) AGERL3MBTL1MAPTMEN1KMT2A
SCHEMBL3058586 0.77 GRIN2D (0.51) GRIN2BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3690613 0.77 GRIN2D (0.58) GRIN2BGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL27527274 0.76 GRIN2D (0.54) GRIN2BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL27675597 0.76 HSD11B1 (0.50) L3MBTL1MAPTMEN1KMT2APOLB
SCHEMBL3454964 0.75 AGER (0.56) AGERL3MBTL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed